Screener
Eikon Therapeutics, Inc. EIKN Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use assets, net | 91,066 | 90,965 |
| Marketable securities, non-current | 83,828 | — |
| Restricted cash, non-current | 7,808 | 7,771 |
| Other non-current assets | 556 | 4,183 |
| Total assets | $850,826 | $594,734 |
| Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | $6,005 | $681 |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Eikon Therapeutics, Inc. (EIKN) reported deferred tax assets and other non-current assets of $556K in Q1 2026.
Ask your AI about Eikon Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude